Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹1,801.1Prev. Close
₹1,788.8Turnover(Lac.)
₹1,376.49Day's High
₹1,818.2Day's Low
₹1,773.752 Week's High
₹1,94052 Week's Low
₹1,137.5Book Value
₹192.37Face Value
₹1Mkt Cap (₹ Cr.)
28,018.29P/E
51.51EPS
35.01Divi. Yield
0.3430 Jun 2023
12:00 AM
AGM
Announcement Date: 30 Jun, 2023
24 May 2023
12:00 AM
Split
10 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
6 Feb 2024
12:00 AM
Dividend
Dividend Amount: 5.5
Record Date: 16 Feb, 2024
28 Jul 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 15.51 | 15.46 | 15.46 | 15.46 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,426.98 | 2,088.21 | 1,791 | 1,429.83 |
Net Worth | 2,442.49 | 2,103.67 | 1,806.46 | 1,445.29 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,189.87 | 1,891.99 | 1,640.74 | 1,250.13 |
yoy growth (%) | 15.74 | 15.31 | 31.24 | 6.42 |
Raw materials | -743.69 | -625.75 | -569.13 | -479.67 |
As % of sales | 33.96 | 33.07 | 34.68 | 38.36 |
Employee costs | -399.06 | -305.97 | -293.78 | -217.3 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 471.29 | 593.7 | 349.56 | 179.04 |
Depreciation | -71.28 | -67.35 | -65.09 | -55.94 |
Tax paid | -110.29 | -146.62 | -71.41 | -51.04 |
Working capital | 298.14 | 110.36 | 28.72 | 67.62 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.74 | 15.31 | 31.24 | 6.42 |
Op profit growth | -7.84 | 49.09 | 85.51 | -10.11 |
EBIT growth | -20.74 | 70.46 | 93.19 | -17.73 |
Net profit growth | -19.25 | 66.73 | 109.48 | -25.99 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 | 1,774.73 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 | 1,774.73 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 37.27 | 9.94 | 39.23 | 112.38 | 50.67 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,520 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,559.2 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,478.4 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,099.05 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,475.05 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec. & Independent Dir.
Padmini Khare Kaicker
Non-Exec. & Independent Dir.
Sumit Bose
Chairman & Independent Directo
Ranjit Shahani.
Non-Exec & Non-Independent Dir
Prashant Kumar.
Whole Time Director & CEO
Nikhil Chopra
Non-Exec & Non-Independent Dir
GAURAV TREHAN
Company Sec. & Compli. Officer
SANDEEP PHADNIS
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by J B Chemicals & Pharmaceuticals Ltd
Summary
J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.95. Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the companys sales. JBC has its subsidiaries namely Lekar Healthcare Ltd and J.B Life Science Overseas Ltd. JBC had a tie-up with Justesa Imagen, Spain, to manufacture and market radio diagnostics under the Trazograf brand name. JBC has also diversified into high-growth agro-based products by acquiring McDa Agro (MAL). The products manufactured by MAL complement fertilisers and increase crop productivity. It has entered into a MoU with GNFC to distribute these products locally. The pharmaceutical divisions of Ifiunik Pharmaceuticals and Unique Pharmaceutical Laboratories has been merged into the company with effect from April 2000.Unique Chemicals (A Division of the company) manufacturing and marketing Bulk Drugs has been awarded Certificate of Suitability to Europeon Pharmacopoeia Monograph for Nifedipine EP from Europeon Directorate for the Quality Medicines.In F
Read More
What is the J B Chemicals & Pharmaceuticals Ltd share price today?
The J B Chemicals & Pharmaceuticals Ltd shares price on nse is Rs.₹1805.15 today.
What is the Market Cap of J B Chemicals & Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of J B Chemicals & Pharmaceuticals Ltd is ₹28018.29 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of J B Chemicals & Pharmaceuticals Ltd?
The PE and PB ratios of J B Chemicals & Pharmaceuticals Ltd is 51.51 and 9.70 as of 03 Jul ‘24
What is the 52 Week High and Low of J B Chemicals & Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a J B Chemicals & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of J B Chemicals & Pharmaceuticals Ltd is ₹1137.5 and ₹1940 as of 03 Jul ‘24
What is the CAGR of J B Chemicals & Pharmaceuticals Ltd?
J B Chemicals & Pharmaceuticals Ltd's CAGR for 5 Years at 57.05%, 3 Years at 24.32%, 1 Year at 51.45%, 6 Month at 9.03%, 3 Month at 6.81% and 1 Month at 0.38%.
What is the shareholding pattern of J B Chemicals & Pharmaceuticals Ltd?
The shareholding pattern of J B Chemicals & Pharmaceuticals Ltd is as follows:
Promoters - 53.78 %
Institutions - 29.44 %
Public - 16.78 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
